Revolution Medicines (RVMD) Gains from Investment Securities (2018 - 2026)
Revolution Medicines' quarterly Gains from Investment Securities came in at $15.8 million in Q1 2026, up 1135.7% year-on-year from $1.3 million in Q1 2025, and up 170.3% quarter-over-quarter from -$22.5 million in Q4 2025.
Revolution Medicines has reported Gains from Investment Securities for 9 years, with the latest figure at $15.8 million in Q1 2026.
- For the quarter ending Q1 2026, Gains from Investment Securities rose 1135.7% year-over-year to $15.8 million; the trailing twelve-month figure through Mar 2026 stood at -$7.6 million (down 694.84% YoY), and the FY2025 full-year result was $18.0 million, up 28.69% from the prior year.
- Gains from Investment Securities for Q1 2026 stood at $15.8 million, up from -$22.5 million in the prior quarter.
- The five-year high for Gains from Investment Securities was $15.8 million in Q1 2026, with the low at -$22.5 million in Q4 2025.
- Average Gains from Investment Securities over 5 years is $2.5 million, with a median of $2.0 million recorded in 2022.
- Year-over-year, Gains from Investment Securities soared 3572.12% in 2022 and tumbled 2689.81% in 2025.
- Tracing RVMD's Gains from Investment Securities over 5 years: stood at $3.8 million in 2022, then sank by 42.26% to $2.2 million in 2023, then slumped by 136.51% to -$805000.0 in 2024, then plunged by 2689.81% to -$22.5 million in 2025, then jumped by 170.3% to $15.8 million in 2026.
- The last three Gains from Investment Securities figures came in at $15.8 million (Q1 2026), -$22.5 million (Q4 2025), and $4.3 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn |
| 10 | Revolution Medicines | 31.20 Bn | 31.20 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 15.79 Mn |
| Mar 31, 2026 | 15.79 Mn |
| Dec 31, 2025 | -22.46 Mn |
| Dec 31, 2025 | -22.46 Mn |
| Sep 30, 2025 | 4.34 Mn |
| Sep 30, 2025 | 4.34 Mn |
| Jun 30, 2025 | 1.68 Mn |
| Jun 30, 2025 | 1.68 Mn |
| Mar 31, 2025 | 1.28 Mn |
| Mar 31, 2025 | 1.28 Mn |
| Dec 31, 2024 | -805,000.00 |
| Dec 31, 2024 | -805,000.00 |
| Sep 30, 2024 | 285,271.00 |
| Sep 30, 2024 | 285,271.00 |
| Jun 30, 2024 | 13.81 Mn |
| Jun 30, 2024 | 13.81 Mn |
| Mar 31, 2024 | -125,000.00 |
| Mar 31, 2024 | -125,000.00 |
| Dec 31, 2023 | 2.21 Mn |
| Dec 31, 2023 | 2.21 Mn |
| Sep 30, 2023 | 1.40 Mn |
| Sep 30, 2023 | 1.40 Mn |
| Jun 30, 2023 | 2.90 Mn |
| Jun 30, 2023 | 2.90 Mn |
| Mar 31, 2023 | 936,344.00 |
| Mar 31, 2023 | 936,344.00 |
| Dec 31, 2022 | 3.82 Mn |
| Dec 31, 2022 | 3.82 Mn |
| Sep 30, 2022 | 8.16 Mn |
| Sep 30, 2022 | 8.16 Mn |
| Jun 30, 2022 | 8.03 Mn |
| Jun 30, 2022 | 8.03 Mn |
| Mar 31, 2022 | 1.95 Mn |
| Mar 31, 2022 | 1.95 Mn |
| Dec 31, 2021 | 104,000.00 |
| Dec 31, 2021 | 104,000.00 |
| Sep 30, 2021 | 395,577.00 |
| Sep 30, 2021 | 395,577.00 |
| Jun 30, 2021 | 343,797.00 |
| Jun 30, 2021 | 343,797.00 |
| Mar 31, 2021 | 273,471.00 |
| Mar 31, 2021 | 273,471.00 |
| Dec 31, 2020 | -21.19 Mn |
| Dec 31, 2020 | -21.19 Mn |
| Sep 30, 2020 | 61,807.00 |
| Sep 30, 2020 | 61,807.00 |
| Jun 30, 2020 | 5.69 Mn |
| Jun 30, 2020 | 5.69 Mn |
| Mar 31, 2020 | 5.57 Mn |
| Mar 31, 2020 | 5.57 Mn |
| Dec 31, 2019 | -859,000.00 |
| Dec 31, 2019 | -859,000.00 |
| Sep 30, 2019 | 1.19 Mn |
| Sep 30, 2019 | 1.19 Mn |
| Jun 30, 2019 | 61,000.00 |
| Jun 30, 2019 | 61,000.00 |
| Mar 31, 2019 | 4,000.00 |
| Mar 31, 2019 | 4,000.00 |
| Dec 31, 2018 | 1.63 Mn |
| Dec 31, 2018 | 1.63 Mn |